We arranged a regional lung cancer meeting with appr 100 participants. We have had talks at national and international meetings, and are PIs on several translational and clinical studies. Currently 17 clinical studies for lung cancer patients are ongoing.
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
Aging (Albany NY), 11 (16), 6312-6335
Increase in curative treatment and survival of lung cancer in Norway 2001-2016
Eur J Epidemiol (in press)